October 9, 2023 from 12:00 pm – 12:45 pm HST
Supported By: GlaxoSmithKline
Join our Pulmonary and Allergy experts as they discuss the next frontier of severe asthma care and the endpoints that may define clinical remission. Review the unmet need that underlies this ambition and what we have learned and can apply from other disease areas. Debate next steps as we strive to raise the ambition of remission on treatment for severe asthma patients.
This is a non-CME event and does not qualify for CME or CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2023 conference sessions. This event is not endorsed by CHEST and does not reflect the views or opinions of CHEST. This presentation is sponsored by GSK, is considered non-promotional and is intended to support disease state education.
John Oppenheimer, MD
Pulmonary and Allergy Associates
Director of Clinical Research
Clinical Professor of Medicine
Cedar Knolls, NJ
Thomas Corbridge, MD, FCCP
Medical Affairs Lead – GSK USMA, Respiratory Biologics
Emeritus Physician, Northwestern Memorial Hospital
Resource Link: GSK US Medical Respiratory – Disease Education